Makiko Omori

Makiko Omori

Auto-generated profile, based on publicly available information

Makiko Omori

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
MOMakiko Omori
Makiko Omori
AHAkihiko Hashi
Akihiko Hashi
KNKumiko Nakazawa
Kumiko Nakazawa
TYTsutomu Yuminamochi
Tsutomu Yuminamochi
TYTetsu Yamane
Tetsu Yamane
KHKazuhiko Hoshi
Kazuhiko Hoshi
The present study used immunohistochemical staining and in situ hybridization (ISH) to examine whether progression of cervical intraepithelial neopla

15 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MOMakiko Omori
Makiko Omori
TKTetsuo Kondo
Tetsuo Kondo
HTHikaru Tagaya
Hikaru Tagaya
YWYumika Watanabe
Yumika Watanabe
HFHiroko Fukasawa
Hiroko Fukasawa
SHShuji Hirata
Shuji Hirata
To investigate the use of imaging methods for predicting carcinogenesis in lobular endocervical glandular hyperplasia (LEGH). We retrospectively analyzed preoperative images on transvaginal sonography and magnetic resonance imaging (MRI) in 23 cases with histologically diagnosed LEGH. Shape of cervical multicystic lesions on MR images could be divided into two types the flower-type with many small cysts surrounded by larger cysts, and the raspberry-type with many tiny, closely aggregated cysts. Six (46%) of 13 cases had raspberry-type lesions that were not detected on transvaginal sonography but were seen on MRI. Adenocarcinoma in situ (AIS) was identified in 4 postmenopausal women with raspberry-type lesions during the follow-up periods. In these cases, cytologic examination by targeted endocervical sampling using sonography enabled early detection of AIS. MRI and cytologic examination by targeted endocervical sampling may be very useful for predicting carcinogenesis in LEGH.

5 July 2018 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
MOMakiko Omori
Makiko Omori
TKTetsuo Kondo
Tetsuo Kondo
KNKumiko Nakazawa
Kumiko Nakazawa
HTHikaru Tagaya
Hikaru Tagaya
MOMaki Ohgi
Maki Ohgi
SHShuji Hirata
Shuji Hirata
Early detection of endocervical adenocarcinoma is especially important for cancers that are human papillomavirus (HPV) negative. We investigated the clinicopathologic significance of yellow gastric-type mucin observed on Papanicolaou smears. We described “atypical endocervical cells with gastric-type mucin” (AEC-GAM) when yellow mucin was observed in endocervical cells. We retrieved AEC-GAM samples from 58,752 cervical smears performed at Yamanashi University Hospital during our study period and reviewed clinical, cytologic, and pathologic features. We detected AEC-GAM in 172 (0.29 %) smears from 65 patients, and 41 of these 65 patients were histologically diagnosed with lobular endocervical glandular hyperplasia (LEGH) (43%) or pyloric gland metaplasia (20%). The prevalence of adenocarcinoma was 25% (7/28) in LEGH cases and 11% (7/65) in AEC-GAM smears. Yellow mucin is a diagnostic clue for endocervical glandular lesions with gastric differentiation. We recommend describing AEC-GAM on cytologic reports to improve cytologic screening for HPV-negative cervical cancers.

1 October 2008 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
MOMakiko Omori
Makiko Omori
AHAkihiko Hashi
Akihiko Hashi
YIYoshio Ishii
Yoshio Ishii
TYTsutomu Yuminamochi
Tsutomu Yuminamochi
MNMasatoshi Nara
Masatoshi Nara
KHKazuhiko Hoshi
Kazuhiko Hoshi
The present study evaluated the clinical impact of preoperative screening for gastric mucin in cervical discharge, using a latex agglutination test w

21 January 2015 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
MOMakiko Omori
Makiko Omori
TKTetsuo Kondo
Tetsuo Kondo
TYTsutomu Yuminamochi
Tsutomu Yuminamochi
KNKumiko Nakazawa
Kumiko Nakazawa
YIYoshio Ishii
Yoshio Ishii
SHShuji Hirata
Shuji Hirata

1 March 2015 in International Journal of Gynecological Pathology
Verified
Journal Article
Closed access
MOMakiko M.D. Omori
Makiko M.D. Omori
AHAkihiko M.D. Hashi
Akihiko M.D. Hashi
TKTetsuo M.D. Kondo
Tetsuo M.D. Kondo
RKRyohei M.D. Katoh
Ryohei M.D. Katoh
SHShuji M.D. Hirata
Shuji M.D. Hirata
Human papillomavirus (HPV)-negative adenocarcinoma (AC) is a minor subset of endocervical cancer, but its pathogenesis has yet to be elucidated. This study investigated the clinicopathologic features of HPV-negative endocervical AC (n=14) in comparison with HPV-positive endocervical AC (n=30), and further studied aberrations of cell-cycle regulators. Expression patterns of cyclin-dependent kinase inhibitors (p16, p14, p27, and p21) and p53 were evaluated immunohistochemically, and nuclear high-risk HPV DNA signals were detected by in situ hybridization and polymerase chain reaction. Immunoexpression of p16, p14, p27, p21, and p53 were observed in 90%, 67%, 77%, 40%, and 20% of HPV-positive ACs, and in 0%, 0%, 29%, 14%, and 57% of HPV-negative ACs, respectively. A higher frequency of lymph node metastasis and worse prognosis were significantly associated with HPV-negative AC. Our findings suggest that alteration of cyclin-dependent kinase inhibitors and p53 status may contribute to carcinogenesis and the clinical behavior of HPV-negative AC of the uterine cervix.